Interleukin-2 rescues helpless effector CD8 + T cells by diminishing the susceptibility to TRAIL mediated death

Immunology Letters

Volumn 139, Issue 1-2, 2011, Pages 25-32

  Wolkers, Monika C ^a   Bensinger, Steven J ^a,b   Green, Douglas R ^a,c   Schoenberger, Stephen P ^a   Janssen, Edith M ^a,d  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CD8; Cytokines; Cytotoxic; T cells; TRAIL

Indexed keywords

DEATH RECEPTOR 5; FLICE INHIBITORY PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; CYTOKINES; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 79960696772     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.04.011     Document Type: Article

References (31)

1. Butz E.A., Bevan M.J. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998, 8:167-175.
2. Callan M.F., Tan L., Annels N., Ogg G.S., Wilson J.D., O'Callaghan C.A., et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med 1998, 187:1395-1402.
3. Doherty P.C. The numbers game for virus-specific CD8+ T cells. Science 1998, 280:227.
4. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J., Zajac A.J., Miller J.D., et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8:177-187.
5. Dutton R.W., Bradley L.M., Swain S.L. T cell memory. Annu Rev Immunol 1998, 16:201-223.
6. Sprent J., Tough D.F. T cell death and memory. Science 2001, 293:245-248.
7. van Stipdonk M.J., Lemmens E.E., Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2001, 2:423-429.
8. van Stipdonk M.J., Hardenberg G., Bijker M.S., Lemmens E.E., Droin N.M., Green D.R., et al. Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol 2003, 4:361-365.
9. Badovinac V.P., Porter B.B., Harty J.T. Programmed contraction of CD8+ T cells after infection. Nat Immunol 2002, 3:619-626.
10. Kaech S.M., Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001, 2:415-422.
11. Teixeiro E., Daniels M.A., Hamilton S.E., Schrum A.G., Bragado R., Jameson S.C., et al. cell receptor signals determine CD8+ memory versus effector development. Science 2009, 323:502-505.
12. Janssen E.M., Lemmens E.E., Wolfe T., Christen U., von Herrath M.G., Schoenberger S.P. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003, 421:852-856.
13. Bourgeois C., Rocha B., Tanchot C. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 2002, 297:2060-2063.
14. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003, 300:337-339.
15. Sun J.C., Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003, 300:339-342.
16. Janssen E.M., Droin N.M., Lemmens E.E., Pinkoski M.J., Bensinger S.J., Ehst B.D., et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005, 434:88-93.
17. Hamilton S.E., Wolkers M.C., Schoenberger S.P., Jameson S.C. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol 2006, 7:475-481.
18. Oh S., Perera L.P., Terabe M., Ni L., Waldmann T.A., Berzofsky J.A. IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc Natl Acad Sci U S A 2008, 105:5201-5206.
19. Schoenberger S.P., van der Voort E.I., Krietemeijer G.M., Offringa R., Melief C.J., Toes R.E. Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells. J Immunol 1998, 161:3808-3812.
20. Takeda K., Yamaguchi N., Akiba H., Kojima Y., Hayakawa Y., Tanner J.E., et al. Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. J Exp Med 2004, 199:437-448.
21. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991, 145:185-192.
22. Budd R.C., Yeh W.C., Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 2006, 6:196-204.
23. Guo B.C., Xu Y.H. Bcl-2 over-expression and activation of protein kinase C suppress the trail-induced apoptosis in Jurkat T cells. Cell Res 2001, 11:101-106.
24. Decaluwe H., Taillardet M., Corcuff E., Munitic I., Law H.K., Rocha B., et al. Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors. Proc Natl Acad Sci U S A 2010, 107:9311-9316.
25. Williams M.A., Tyznik A.J., Bevan M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006, 441:890-893.
26. Barker B.R., Gladstone M.N., Gillard G.O., Panas M.W., Letvin N.L. Critical role for IL-21 in both primary and memory anti-viral CD8+ T-cell responses. Eur J Immunol 2010, 40:3085-3096.
27. Obar J.J., Molloy M.J., Jellison E.R., Stoklasek T.A., Zhang W., Usherwood E.J., et al. CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses. Proc Natl Acad Sci U S A 2010, 107:193-198.
28. Wiesel M., Joller N., Ehlert A.K., Crouse J., Sporri R., Bachmann M.F., et al. Th cells act via two synergistic pathways to promote antiviral CD8+ T cell responses. J Immunol 2010, 185:5188-5197.
29. Overwijk W.W., Theoret M.R., Restifo N.P. The future of interleukin-2: enhancing therapeutic anticancer vaccines. Cancer J Sci Am 2000, 6(Suppl. 1):S76-80.
30. McDermott D.F., Atkins M.B. Immunotherapy of metastatic renal cell carcinoma. Cancer J 2008, 14:320-324.
31. Boyman O., Surh C.D., Sprent J. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin Biol Ther 2006, 6:1323-1331.